Daniel Courchesne

Directeur/Bestuurslid bij F3 Platform Biologics, Inc.

Finance

Consumer Services

Health Technology

Actieve functies van Daniel Courchesne

Bedrijven	Functie	Begin	Einde
F3 Platform Biologics, Inc. F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA.	Directeur/Bestuurslid	04-10-2019	-

Bedrijven	Functie	Begin	Einde
Global One Financial, Inc.	President	-	-
ROYAL BANK OF CANADA	Corporate Officer/Principal	-	-
NATIONAL BANK OF CANADA	Corporate Officer/Principal	-	-
Entaire Global Cos., Inc. Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA.	Corporate Officer/Principal	01-06-2010	-

University of Sherbrooke

Undergraduate Degree

Internationaal

Verenigde Staten	4
Canada	4

Operationeel

Corporate Officer/Principal	3
Undergraduate Degree	1
Director/Board Member	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
ROYAL BANK OF CANADA	Finance
NATIONAL BANK OF CANADA	Finance

Bedrijven in privébezit	3
Entaire Global Cos., Inc. Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA.	Finance
F3 Platform Biologics, Inc. F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA.	Health Technology
Global One Financial, Inc.